Welcome to the December issue of The Pharmafile Brief, where we bring you the latest developments and conversations shaping healthcare, life sciences and pharma.
This month, as part of our Gateway to Local Adoption series, Visions4Health spoke to Julian Wenman, senior operations manager in oncology and haematology at the University Hospitals Tees (Group) Cancer Institute.
His article looks at the NHS 10-Year Health Plan’s ambition to shift care from hospitals to communities. Wenman writes that, while many treatments should be moved closer to home, effective pathways and partnerships have to be put in place first. Key initiatives include identifying which services are safe and effective enough to warrant community-based care, and forging creative, place-based partnerships that rethink where and how treatment happens.

Women’s bone health is another key topic, with Tina Backhouse writing about osteoporosis and the importance of universal Fracture Liaison Services (FLS) access. Backhouse notes that women bear the overwhelming burden of osteoporosis in the UK, suffering far more life-altering and life-limiting fractures than men. She writes about the steps the NHS and government could take in making FLS accessible to all, ensuring that over-50s with fragility fracture are assessed and, if necessary, treated for osteoporosis.
We report on a men’s health study from the UK Department of Health and Social Care that found that almost half of men thought mental health support needed to be a priority, with flagged issues including timely mental health care and suicide prevention. This links up with a story in our news round-up about how brain stimulation could help patients struggling to access mental health support.

Another key topic in this issue is the importance of safeguarding employee health and well-being. The article looks at the value of occupational health services, highlighting the CIPD’s 2025 Health and Wellbeing at Work report showing that, in 2024, employees took off an average of 9.4 days compared with 5.8 before the COVID-19 pandemic in 2019 – and an increase on the 7.8 days reported in 2023.

Marking November’s AMR Awareness Week, our Five Facts feature looks at the ongoing issues of antimicrobial resistance and the changes being implemented to slow its spread.

In this month’s news round-up, a new study investigated brain stimulation as a treatment for depression. Accession Therapeutics dosed the first patient in its new cancer immunotherapy trial, and Vesper Bio reported positive topline results for its new dementia candidate. Novartis announced that its early breast cancer treatment was approved by the Scottish Medicines Consortium for use within NHS Scotland.
There were also several important industry appointments this month: ViVac Pharma appointed Keren Leshem as CEO; Ardena appointed Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer, and Richmond Pharmacology appointed Dr Edward Jackson as Medical Director.
We hope you enjoy reading this issue of The Pharmafile Brief – look out for our next issue in January!

Published on December 1st, 2025

Published on November 28th, 2025

Published on November 28th, 2025

Published on November 28th, 2025

Published on November 26th, 2025

Published on November 26th, 2025

Published on November 21st, 2025

Published on November 14th, 2025

Published on November 11th, 2025

Published on November 7th, 2025

Published on November 7th, 2025

Published on November 6th, 2025